Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 818731

Endothelins -- clinical perspectives


Unić, Adriana; Derek, Lovorka; Hodak, Nataša; Marijančević, Domagoj; Čeprnja, Marina; Serdar, Tihana; Krhač, Maja; Romić, Željko
Endothelins -- clinical perspectives // Biochemia medica : časopis hrvatskoga društva medicinskih biokemičara, 21 (2011), 3; 231-242 doi:10.11613/BM.2011.032 (međunarodna recenzija, pregledni rad, znanstveni)


CROSBI ID: 818731 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Endothelins -- clinical perspectives

Autori
Unić, Adriana ; Derek, Lovorka ; Hodak, Nataša ; Marijančević, Domagoj ; Čeprnja, Marina ; Serdar, Tihana ; Krhač, Maja ; Romić, Željko

Izvornik
Biochemia medica : časopis hrvatskoga društva medicinskih biokemičara (1330-0962) 21 (2011), 3; 231-242

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, pregledni rad, znanstveni

Ključne riječi
endothelin 1 ; endothelin receptor ; endothelin receptor antagonist ; endothelin converting enzyme

Sažetak
Endothelins (ET) are a group of endogenous peptides, which have a strong and long-lasting vasoconstrictive effect. Three isoforms of endothelins coded by three different genes have been identified to date. Endothelin-1 (ET-1) is the most potent vasoconstrictive agent currently identified, and it was originally isolated and characterized from the culture media of aortic endothelial cells. Two other isoforms, named endothelin-2 (ET-2) and endothelin-3 (ET- 3), were subsequently identified, along with structural homologues isolated from the venom of Actractapis engaddensis known as the sarafotoxins. The biological effects of endothelin production are determined via activation of one or two G- protein coupled receptors, endothelin receptors A (ETRA) and B (ETRB1 and ETRB2). Recently endothelin receptor C (ETRC) was discovered, however, its functions and distribution still remain unclear. The effects mediated by ET-1 via ETRA are vasoconstriction, bronchoconstriction and secretion of aldosterone. Agonists related to the ETRB1 activation cause vasodilatation by stimulating NO, PGI2 and endothelium- derived hyperpolarizing factor (EDHF). In contrast, coupling to ETRB2 causes vasoconstriction. Involvement of ET has been demonstrated in the pathophysiology of certain disorders. In this review, we discuss the physiological and pathophysiological role of endothelium-derived ET-1, the pharmacology of its two receptors, focusing on the role of ET-1 in the development of some pathophysiological conditions.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti



POVEZANOST RADA


Ustanove:
Klinička bolnica "Dubrava"

Poveznice na cjeloviti tekst rada:

doi www.biochemia-medica.com

Citiraj ovu publikaciju:

Unić, Adriana; Derek, Lovorka; Hodak, Nataša; Marijančević, Domagoj; Čeprnja, Marina; Serdar, Tihana; Krhač, Maja; Romić, Željko
Endothelins -- clinical perspectives // Biochemia medica : časopis hrvatskoga društva medicinskih biokemičara, 21 (2011), 3; 231-242 doi:10.11613/BM.2011.032 (međunarodna recenzija, pregledni rad, znanstveni)
Unić, A., Derek, L., Hodak, N., Marijančević, D., Čeprnja, M., Serdar, T., Krhač, M. & Romić, Ž. (2011) Endothelins -- clinical perspectives. Biochemia medica : časopis hrvatskoga društva medicinskih biokemičara, 21 (3), 231-242 doi:10.11613/BM.2011.032.
@article{article, author = {Uni\'{c}, Adriana and Derek, Lovorka and Hodak, Nata\v{s}a and Marijan\v{c}evi\'{c}, Domagoj and \v{C}eprnja, Marina and Serdar, Tihana and Krha\v{c}, Maja and Romi\'{c}, \v{Z}eljko}, year = {2011}, pages = {231-242}, DOI = {10.11613/BM.2011.032}, keywords = {endothelin 1, endothelin receptor, endothelin receptor antagonist, endothelin converting enzyme}, journal = {Biochemia medica : \v{c}asopis hrvatskoga dru\v{s}tva medicinskih biokemi\v{c}ara}, doi = {10.11613/BM.2011.032}, volume = {21}, number = {3}, issn = {1330-0962}, title = {Endothelins -- clinical perspectives}, keyword = {endothelin 1, endothelin receptor, endothelin receptor antagonist, endothelin converting enzyme} }
@article{article, author = {Uni\'{c}, Adriana and Derek, Lovorka and Hodak, Nata\v{s}a and Marijan\v{c}evi\'{c}, Domagoj and \v{C}eprnja, Marina and Serdar, Tihana and Krha\v{c}, Maja and Romi\'{c}, \v{Z}eljko}, year = {2011}, pages = {231-242}, DOI = {10.11613/BM.2011.032}, keywords = {endothelin 1, endothelin receptor, endothelin receptor antagonist, endothelin converting enzyme}, journal = {Biochemia medica : \v{c}asopis hrvatskoga dru\v{s}tva medicinskih biokemi\v{c}ara}, doi = {10.11613/BM.2011.032}, volume = {21}, number = {3}, issn = {1330-0962}, title = {Endothelins -- clinical perspectives}, keyword = {endothelin 1, endothelin receptor, endothelin receptor antagonist, endothelin converting enzyme} }

Časopis indeksira:


  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE


Citati:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font